Literature DB >> 10760291

Evidence for regulation of the PTEN tumor suppressor by a membrane-localized multi-PDZ domain containing scaffold protein MAGI-2.

X Wu1, K Hepner, S Castelino-Prabhu, D Do, M B Kaye, X J Yuan, J Wood, C Ross, C L Sawyers, Y E Whang.   

Abstract

PTEN is a tumor suppressor gene mutated in human cancers. Although many mutations target the phosphatase domain, others create a truncated protein lacking the C-terminal PDZ-binding motif or a protein that extends beyond the PDZ-binding motif. Using the yeast two-hybrid system, we isolated a membrane-associated guanylate kinase family protein with multiple PDZ domains [AIP-1 (atrophin interacting protein 1), renamed MAGI-2 (membrane associated guanylate kinase inverted-2)]. MAGI-2 contains eight potential protein-protein interaction domains and is localized to tight junctions in the membrane of epithelial cells. PTEN binds to MAGI-2 through an interaction between the PDZ-binding motif of PTEN and the second PDZ domain of MAGI-2. MAGI-2 enhances the ability of PTEN to suppress Akt activation. Furthermore, certain PTEN mutants have reduced stability, which is restored by adding the minimal PDZ-binding motif back to the truncated protein. We propose that MAGI-2 improves the efficiency of PTEN signaling through assembly of a multiprotein complex at the cell membrane.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10760291      PMCID: PMC18208          DOI: 10.1073/pnas.97.8.4233

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  51 in total

1.  The discs-large tumor suppressor gene of Drosophila encodes a guanylate kinase homolog localized at septate junctions.

Authors:  D F Woods; P J Bryant
Journal:  Cell       Date:  1991-08-09       Impact factor: 41.582

2.  Threonine phosphorylation of the MMAC1/PTEN PDZ binding domain both inhibits and stimulates PDZ binding.

Authors:  N B Adey; L Huang; P A Ormonde; M L Baumgard; R Pero; D V Byreddy; S V Tavtigian; P L Bartel
Journal:  Cancer Res       Date:  2000-01-01       Impact factor: 12.701

3.  Identification and characterization of a PDZ protein that interacts with activin type II receptors.

Authors:  H Shoji; K Tsuchida; H Kishi; N Yamakawa; T Matsuzaki; Z Liu; T Nakamura; H Sugino
Journal:  J Biol Chem       Date:  2000-02-25       Impact factor: 5.157

4.  Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association.

Authors:  J O Lee; H Yang; M M Georgescu; A Di Cristofano; T Maehama; Y Shi; J E Dixon; P Pandolfi; N P Pavletich
Journal:  Cell       Date:  1999-10-29       Impact factor: 41.582

Review 5.  Mutational spectra of PTEN/MMAC1 gene: a tumor suppressor with lipid phosphatase activity.

Authors:  I U Ali; L M Schriml; M Dean
Journal:  J Natl Cancer Inst       Date:  1999-11-17       Impact factor: 13.506

6.  The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53.

Authors:  M Scheffner; B A Werness; J M Huibregtse; A J Levine; P M Howley
Journal:  Cell       Date:  1990-12-21       Impact factor: 41.582

7.  Phenotypic analysis of human glioma cells expressing the MMAC1 tumor suppressor phosphatase.

Authors:  A M Morimoto; A E Berson; G H Fujii; D H Teng; S V Tavtigian; R Bookstein; P A Steck; J B Bolen
Journal:  Oncogene       Date:  1999-02-11       Impact factor: 9.867

8.  Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems.

Authors:  K Podsypanina; L H Ellenson; A Nemes; J Gu; M Tamura; K M Yamada; C Cordon-Cardo; G Catoretti; P E Fisher; R Parsons
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

9.  Chromosomal abnormalities in glioblastoma multiforme tumors and glioma cell lines detected by comparative genomic hybridization.

Authors:  D H Kim; G Mohapatra; A Bollen; F M Waldman; B G Feuerstein
Journal:  Int J Cancer       Date:  1995-03-16       Impact factor: 7.396

10.  Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27.

Authors:  M Pagano; S W Tam; A M Theodoras; P Beer-Romero; G Del Sal; V Chau; P R Yew; G F Draetta; M Rolfe
Journal:  Science       Date:  1995-08-04       Impact factor: 47.728

View more
  123 in total

1.  PTEN controls tumor-induced angiogenesis.

Authors:  S Wen; J Stolarov; M P Myers; J D Su; M H Wigler; N K Tonks; D L Durden
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

2.  Selective PDZ protein-dependent stimulation of phosphatidylinositol 3-kinase by the adenovirus E4-ORF1 oncoprotein.

Authors:  Kristopher K Frese; Siu Sylvia Lee; Darby L Thomas; Isabel J Latorre; Robert S Weiss; Britt A Glaunsinger; Ronald T Javier
Journal:  Oncogene       Date:  2003-02-06       Impact factor: 9.867

3.  Membrane-binding and activation mechanism of PTEN.

Authors:  Sudipto Das; Jack E Dixon; Wonhwa Cho
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-13       Impact factor: 11.205

4.  Redox regulation of PI 3-kinase signalling via inactivation of PTEN.

Authors:  Nick R Leslie; Deborah Bennett; Yvonne E Lindsay; Hazel Stewart; Alex Gray; C Peter Downes
Journal:  EMBO J       Date:  2003-10-15       Impact factor: 11.598

5.  Evolution of metazoan cell junction proteins: the scaffold protein MAGI and the transmembrane receptor tetraspanin in the demosponge Suberites domuncula.

Authors:  Teresa Adell; Vera Gamulin; Sanja Perović-Ottstadt; Matthias Wiens; Michael Korzhev; Isabel M Müller; Werner E G Müller
Journal:  J Mol Evol       Date:  2004-07       Impact factor: 2.395

Review 6.  The organization of tight junctions in epithelia: implications for mammary gland biology and breast tumorigenesis.

Authors:  Masahiko Itoh; Mina J Bissell
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-10       Impact factor: 2.673

7.  PTEN is recruited to the postsynaptic terminal for NMDA receptor-dependent long-term depression.

Authors:  Sandra Jurado; Marion Benoist; Argentina Lario; Shira Knafo; Cortney N Petrok; José A Esteban
Journal:  EMBO J       Date:  2010-07-13       Impact factor: 11.598

8.  PTEN recruitment controls synaptic and cognitive function in Alzheimer's models.

Authors:  Shira Knafo; Cristina Sánchez-Puelles; Ernest Palomer; Igotz Delgado; Jonathan E Draffin; Janire Mingo; Tina Wahle; Kanwardeep Kaleka; Liping Mou; Inmaculada Pereda-Perez; Edvin Klosi; Erik B Faber; Heidi M Chapman; Laura Lozano-Montes; Ana Ortega-Molina; Lara Ordóñez-Gutiérrez; Francisco Wandosell; Jose Viña; Carlos G Dotti; Randy A Hall; Rafael Pulido; Nashaat Z Gerges; Andrew M Chan; Mark R Spaller; Manuel Serrano; César Venero; José A Esteban
Journal:  Nat Neurosci       Date:  2016-01-18       Impact factor: 24.884

9.  S-SCAM/MAGI-2 is an essential synaptic scaffolding molecule for the GluA2-containing maintenance pool of AMPA receptors.

Authors:  Eric Danielson; Nanyan Zhang; Jacob Metallo; Kanwardeep Kaleka; Seung Min Shin; Nashaat Gerges; Sang H Lee
Journal:  J Neurosci       Date:  2012-05-16       Impact factor: 6.167

10.  Molecular dissection of NRG1-ERBB4 signaling implicates PTPRZ1 as a potential schizophrenia susceptibility gene.

Authors:  J D Buxbaum; L Georgieva; J J Young; C Plescia; Y Kajiwara; Y Jiang; V Moskvina; N Norton; T Peirce; H Williams; N J Craddock; L Carroll; G Corfas; K L Davis; M J Owen; S Harroch; T Sakurai; M C O'Donovan
Journal:  Mol Psychiatry       Date:  2007-04-17       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.